MAPK3 and cardiac hypertrophy: Glycine may be a novel cardioprotector against pressure overload-induced cardiac hypertrophy; the protection of glycine might be mediated by glyR α2 through the MAPK (JNK, ERK1/2, and p38) signaling pathways